Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions revolve around detailed statistical outcomes of the study, such as HR values over 10 and 22 years, and opinions on patient management strategies like PSA testing and biopsies, reflecting moderate interest and engagement. The tone is analytical, referencing survival statistics and clinical practices, which indicates recognition of the study's nuanced implications without dramatic reactions.
The discussions reflect a cautious interpretation of the study's findings, with some emphasis on the nuances of long-term survival data, but there's no strong opposition or full endorsement.
Participants show moderate curiosity about the long-term outcomes and implications, particularly regarding follow-up periods and survival benefits.
Comments cite specific statistics and suggest thoughtfulness, indicating active engagement but not deeply detailed analysis.
The conversations highlight relevant considerations in prostate cancer treatment decisions, suggesting the study influences clinical perspectives without causing widespread change or controversy.
@paulpharoah @GMFranceschini Well, take RPs for prostate cancer (https://t.co/pY2BEAfbTH): 10 year follow-up: HR=0.88, p=0.22 for overall survival; HR=0.6, p=0.09 for disease specific. 20 year fu, HR=0.84, p=0.06 for OS; HR=0.63, p=0.06 for DSS 22 year fu, HR=0.84, p=0.04 for OS.
RT @lugifel: En asintomáticos no pedir PSA. Y si la han hecho y es <10, no hacer biopsia próstata. Dejar de hacer para poder hacer http://…
Whats the truth about prostate cancer treatments. There are many options including surgery, radiation, and focal therapies, but current evidence does not conclusively show they save many lives. The risk of complications…
Prostate cancer awareness campaigns often rely on ineffective tests. PSA blood tests and digital rectal exams have high false positive rates and limited reliability, failing to significantly reduce mortality. This video…
Whats the truth about the PSA test? The PSA test is highly unreliable with a high false positive rate and no proven mortality benefit. Most prostate cancers are outlived, and screening may cause more harm than good.
Prostate cancer screening is highly unreliable, with PSA levels often misleading. High false positive rates and inability to distinguish aggressive cancers question its effectiveness in saving lives.
Prostate health refers to the wellbeing of the prostate gland, a crucial organ in male reproductive and urinary health. Prostate cancer awareness programs aim to promote screenings and support, but recent studies…
Men's Health Month in June aims to raise awareness of preventable health issues, promote early detection, and encourage healthy lifestyles. It also includes prostate cancer awareness, which focuses on early screening…
@paulpharoah @GMFranceschini Well, take RPs for prostate cancer (https://t.co/pY2BEAfbTH): 10 year follow-up: HR=0.88, p=0.22 for overall survival; HR=0.6, p=0.09 for disease specific. 20 year fu, HR=0.84, p=0.06 for OS; HR=0.63, p=0.06 for DSS 22 year fu, HR=0.84, p=0.04 for OS.
RT @lugifel: En asintomáticos no pedir PSA. Y si la han hecho y es <10, no hacer biopsia próstata. Dejar de hacer para poder hacer http://…